Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2014; 20(7): 1822-1832
Published online Feb 21, 2014. doi: 10.3748/wjg.v20.i7.1822
Published online Feb 21, 2014. doi: 10.3748/wjg.v20.i7.1822
Figure 1 Sophocarpine ameliorates liver function in fibrotic rats.
Serum was collected from each group of rats. AST (A), ALT (B) and TB (C) levels were determined to assess liver function in the sophocarpine-treated group compared to each model group (aP < 0.05, by two-tailed Student’s t test). ALT: Alanine aminotransfer; AST: Aspartate aminotransferase; TB: Total bilirubin; DMN: Dimethylnitrosamine; BDL: Bile duct ligation.
- Citation: Qian H, Shi J, Fan TT, Lv J, Chen SW, Song CY, Zheng ZW, Xie WF, Chen YX. Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats. World J Gastroenterol 2014; 20(7): 1822-1832
- URL: https://www.wjgnet.com/1007-9327/full/v20/i7/1822.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i7.1822